Quick Links: Consensus Ratings,
Ratings History,
Earnings History,
Company Description
Consensus Ratings for Bodycote (LON:BOY) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.| Ratings Breakdown: | 2 Sell Rating(s), 4 Hold Rating(s), 6 Buy Rating(s) |
| Consensus Rating: | Hold |
| Consensus Price Target: | GBX 527.48 |
Analysts' Ratings History for Bodycote (LON:BOY)| Date | Firm | Action | Company | Old Rating | New Rating | Old Price Target | New Price Target | Details |
|---|
| 4/30/2013 | Oriel Securities Ltd | Reiterated Rating | Bodycote (BOY) | Buy | Buy | GBX 550 | GBX 550 | View |
| 4/29/2013 | Jefferies International | Reiterated Rating | Bodycote (BOY) | Buy | Buy | GBX 615 | GBX 605 | View |
| 4/29/2013 | Jefferies Group | Lower Price Target | Bodycote (BOY) | | Buy | GBX 615 | GBX 605 | View |
| 4/25/2013 | Arden Partners Ltd | Reiterated Rating | Bodycote (BOY) | | Reduce | | GBX 450 | View |
| 4/25/2013 | Bank of America | Reiterated Rating | Bodycote (BOY) | Underperform | Underperform | GBX 485 | GBX 485 | View |
| 4/25/2013 | Bank of America | Reiterated Rating | Bodycote (BOY) | | Underperform | GBX 485 | GBX 485 | View |
| 4/24/2013 | FinnCap | Reiterated Rating | Bodycote (BOY) | Hold | Hold | GBX 500 | GBX 500 | View |
| 4/24/2013 | Credit Suisse | Reiterated Rating | Bodycote (BOY) | Outperform | Outperform | GBX 600 | GBX 600 | View |
| 4/24/2013 | Investec | Reiterated Rating | Bodycote (BOY) | Buy | Buy | GBX 635 | GBX 600 | View |
| 4/2/2013 | N+1 Singer | Reiterated Rating | Bodycote (BOY) | | Hold | | GBX 396.11 | View |
| 4/2/2013 | Goldman Sachs | Boost Price Target | Bodycote (BOY) | | Neutral/Neutral | GBX 495.14 | GBX 529.80 | View |
| 3/27/2013 | JPMorgan Chase | Boost Price Target | Bodycote (BOY) | | Neutral | GBX 377.28 | GBX 491.46 | View |
| 3/27/2013 | JP Morgan Cazenove | Boost Price Target | Bodycote (BOY) | | Neutral | GBX 377.28 | GBX 491.46 | View |
| 3/22/2013 | Arden Partners Ltd | Downgrade | Bodycote (BOY) | | Reduce | | GBX 492.30 | View |
| 3/19/2013 | Investec | Reiterated Rating | Bodycote (BOY) | | Buy | | GBX 625.22 | View |
| 3/19/2013 | Credit Suisse | Reiterated Rating | Bodycote (BOY) | | Outperform | | GBX 590.76 | View |
| 3/19/2013 | Investec | Reiterated Rating | Bodycote (BOY) | | Buy | GBX 625.22 | GBX 625.22 | View |
| 3/6/2013 | Jefferies Group | Boost Price Target | Bodycote (BOY) | | Buy | GBX 514.42 | GBX 602.61 | View |
| 3/5/2013 | Goldman Sachs | Boost Price Target | Bodycote (BOY) | | Neutral | GBX 470.33 | GBX 489.93 | View |
| 2/28/2013 | Bank of America | Boost Price Target | Bodycote (BOY) | | Underperform | GBX 449.69 | GBX 479.34 | View |
| 2/27/2013 | Numis Securities Ltd | Reiterated Rating | Bodycote (BOY) | | Add | | GBX 553.46 | View |
| 2/27/2013 | N+1 Singer | Reiterated Rating | Bodycote (BOY) | | Hold | | GBX 395.33 | View |
| 2/27/2013 | Credit Suisse | Boost Price Target | Bodycote (BOY) | | Outperform | GBX 494.16 | GBX 592.99 | View |
| 2/27/2013 | Investec | Upgrade | Bodycote (BOY) | | Buy | | GBX 627.59 | View |
| 2/25/2013 | Oriel Securities Ltd | Reiterated Rating | Bodycote (BOY) | | Buy | | GBX 541.69 | View |
| 1/8/2013 | Jefferies Group | Reiterated Rating | Bodycote (BOY) | | Buy | | GBX 551.48 | View |
| 1/4/2013 | Arden Partners Ltd | Reiterated Rating | Bodycote (BOY) | | Neutral | | GBX 444.91 | View |
| 11/27/2012 | Arden Partners Ltd | Reiterated Rating | Bodycote (BOY) | | neutral | | GBX 386.61 | View |
| 11/6/2012 | JPMorgan Chase | Reiterated Rating | Bodycote (BOY) | | Neutral | | GBX 395.79 | View |
| 10/16/2012 | Arden Partners Ltd | Upgrade | Bodycote (BOY) | | Neutral | | GBX 361.41 | View |
| 10/2/2012 | Oriel Securities Ltd | Initiated Coverage | Bodycote (BOY) | | Buy | | GBX 525.73 | View |
| 9/7/2012 | Arden Partners Ltd | Downgrade | Bodycote (BOY) | | Reduce | | GBX 336.25 | View |
Click Here to view only the most recent ratings from each analyst for this stock.
Earnings History for Bodycote (LON:BOY)No earnings history available
About Bodycote
Bodycote plc (Bodycote) is a specialized plasma spray, high velocity oxy fuel (HVOF) and thermally formed ceramic treatments. It operates in two areas: the Aerospace, Defense and Energy (ADE) business, which serves the aerospace, defense, power generation and oil & gas industries, and the Automotive and General Industrial (AGI) business, which serves sectors, including automotive, construction, agriculture, medical and transportation. Its treatment services consist of technologies: heat treatment and metal joining, hot isostatic pressing (HIP) and surface technology. Heat treatments are controlled processes used to alter the microstructure of materials, such as metals and alloys. HIP combines very high temperature with inert gas under very high pressure. In April 2012, Curtiss-Wright Corporation sold its heat treating business to Bodycote. In October 2012, the Company acquired the business of Carolina Commercial Heat Treating from Bluewater Thermal Solutions LLC.